Profiling methyl-CpG specific determinants on transcriptionally silent chromatin

Assam El-Osta, Emma K. Baker, Alan P. Wolffe

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Transcriptional activity is closely associated with DNA methylation and chromatin remodelling. Evidence is emerging that a family of methylation specific (methyl-CpG binding domain, MBD) proteins have the capacity to bind to methylated sequences and repress transcription. Recent advances in this area reveal that many of the MBD proteins are associated with histone deacetylase (HDAC) dependant repression. The capacity of MBD association to repress transcription would largely be defined by promoter structure and this is best explained by the position and density of DNA methylation. The mechanism of specific targeting of MBD family members to methylated sequences remains largely unknown. In order to understand the mechanistic details of silencing the current challenge is to identify and map these molecular determinants assembled on native chromatin in model systems of human development and disease. Downstream targets such as the methylated Fragile X Mental Retardation gene 1 (FMR1) gene and tumour suppressor genes are likely candidates. In this article, we describe a powerful strategy that involves the immunoprecipitation of in vivo formaldehyde fixed chromatin to identify MBD binding complexes directly isolated from the natural chromosomal environment. We demonstrate the methylated human Multidrug Resistance gene 1 (MDR1) is enriched with transcriptional repressors that belong to the MBD family and this would account for transcriptional silencing.

Original languageEnglish
Pages (from-to)209-215
Number of pages7
JournalMolecular Biology Reports
Volume28
Issue number4
DOIs
Publication statusPublished - 15 Jul 2002
Externally publishedYes

Keywords

  • Chromatin immunoprecipitation (CHIP)
  • Fragile X mental retardation gene 1 (FMR1)
  • Histone deacetylase (HDAC)
  • Methyl-CpG binding domain (MBD)
  • Methylation
  • Multidrug resistance gene 1 (MDR1)
  • Rett Syndrome

Cite this

El-Osta, Assam ; Baker, Emma K. ; Wolffe, Alan P. / Profiling methyl-CpG specific determinants on transcriptionally silent chromatin. In: Molecular Biology Reports. 2002 ; Vol. 28, No. 4. pp. 209-215.
@article{af2481f05b5d4a729dff4324a5e58387,
title = "Profiling methyl-CpG specific determinants on transcriptionally silent chromatin",
abstract = "Transcriptional activity is closely associated with DNA methylation and chromatin remodelling. Evidence is emerging that a family of methylation specific (methyl-CpG binding domain, MBD) proteins have the capacity to bind to methylated sequences and repress transcription. Recent advances in this area reveal that many of the MBD proteins are associated with histone deacetylase (HDAC) dependant repression. The capacity of MBD association to repress transcription would largely be defined by promoter structure and this is best explained by the position and density of DNA methylation. The mechanism of specific targeting of MBD family members to methylated sequences remains largely unknown. In order to understand the mechanistic details of silencing the current challenge is to identify and map these molecular determinants assembled on native chromatin in model systems of human development and disease. Downstream targets such as the methylated Fragile X Mental Retardation gene 1 (FMR1) gene and tumour suppressor genes are likely candidates. In this article, we describe a powerful strategy that involves the immunoprecipitation of in vivo formaldehyde fixed chromatin to identify MBD binding complexes directly isolated from the natural chromosomal environment. We demonstrate the methylated human Multidrug Resistance gene 1 (MDR1) is enriched with transcriptional repressors that belong to the MBD family and this would account for transcriptional silencing.",
keywords = "Chromatin immunoprecipitation (CHIP), Fragile X mental retardation gene 1 (FMR1), Histone deacetylase (HDAC), Methyl-CpG binding domain (MBD), Methylation, Multidrug resistance gene 1 (MDR1), Rett Syndrome",
author = "Assam El-Osta and Baker, {Emma K.} and Wolffe, {Alan P.}",
year = "2002",
month = "7",
day = "15",
doi = "10.1023/A:1015744625049",
language = "English",
volume = "28",
pages = "209--215",
journal = "Molecular Biology Reports",
issn = "0301-4851",
publisher = "Springer-Verlag London Ltd.",
number = "4",

}

Profiling methyl-CpG specific determinants on transcriptionally silent chromatin. / El-Osta, Assam; Baker, Emma K.; Wolffe, Alan P.

In: Molecular Biology Reports, Vol. 28, No. 4, 15.07.2002, p. 209-215.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Profiling methyl-CpG specific determinants on transcriptionally silent chromatin

AU - El-Osta, Assam

AU - Baker, Emma K.

AU - Wolffe, Alan P.

PY - 2002/7/15

Y1 - 2002/7/15

N2 - Transcriptional activity is closely associated with DNA methylation and chromatin remodelling. Evidence is emerging that a family of methylation specific (methyl-CpG binding domain, MBD) proteins have the capacity to bind to methylated sequences and repress transcription. Recent advances in this area reveal that many of the MBD proteins are associated with histone deacetylase (HDAC) dependant repression. The capacity of MBD association to repress transcription would largely be defined by promoter structure and this is best explained by the position and density of DNA methylation. The mechanism of specific targeting of MBD family members to methylated sequences remains largely unknown. In order to understand the mechanistic details of silencing the current challenge is to identify and map these molecular determinants assembled on native chromatin in model systems of human development and disease. Downstream targets such as the methylated Fragile X Mental Retardation gene 1 (FMR1) gene and tumour suppressor genes are likely candidates. In this article, we describe a powerful strategy that involves the immunoprecipitation of in vivo formaldehyde fixed chromatin to identify MBD binding complexes directly isolated from the natural chromosomal environment. We demonstrate the methylated human Multidrug Resistance gene 1 (MDR1) is enriched with transcriptional repressors that belong to the MBD family and this would account for transcriptional silencing.

AB - Transcriptional activity is closely associated with DNA methylation and chromatin remodelling. Evidence is emerging that a family of methylation specific (methyl-CpG binding domain, MBD) proteins have the capacity to bind to methylated sequences and repress transcription. Recent advances in this area reveal that many of the MBD proteins are associated with histone deacetylase (HDAC) dependant repression. The capacity of MBD association to repress transcription would largely be defined by promoter structure and this is best explained by the position and density of DNA methylation. The mechanism of specific targeting of MBD family members to methylated sequences remains largely unknown. In order to understand the mechanistic details of silencing the current challenge is to identify and map these molecular determinants assembled on native chromatin in model systems of human development and disease. Downstream targets such as the methylated Fragile X Mental Retardation gene 1 (FMR1) gene and tumour suppressor genes are likely candidates. In this article, we describe a powerful strategy that involves the immunoprecipitation of in vivo formaldehyde fixed chromatin to identify MBD binding complexes directly isolated from the natural chromosomal environment. We demonstrate the methylated human Multidrug Resistance gene 1 (MDR1) is enriched with transcriptional repressors that belong to the MBD family and this would account for transcriptional silencing.

KW - Chromatin immunoprecipitation (CHIP)

KW - Fragile X mental retardation gene 1 (FMR1)

KW - Histone deacetylase (HDAC)

KW - Methyl-CpG binding domain (MBD)

KW - Methylation

KW - Multidrug resistance gene 1 (MDR1)

KW - Rett Syndrome

UR - http://www.scopus.com/inward/record.url?scp=0036295351&partnerID=8YFLogxK

U2 - 10.1023/A:1015744625049

DO - 10.1023/A:1015744625049

M3 - Article

VL - 28

SP - 209

EP - 215

JO - Molecular Biology Reports

JF - Molecular Biology Reports

SN - 0301-4851

IS - 4

ER -